MedTrace Logo

Intrauterine Embryo Development With ANECOVA Device

NCT00480103 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2011-03-04

No results posted yet for this study

Summary

We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.

Conditions

  • Healthy

Interventions

DEVICE

in vivo (ANECOVA D-1) or in vitro culture in 25-µl droplets of cleavage medium (Medicult®) under paraffin oil

Sponsors & Collaborators

  • Anecova SA

    collaborator INDUSTRY

  • Instituto Valenciano de Infertilidad, IVI VALENCIA

    lead OTHER

Principal Investigators

  • Martin Velasco · Affiliated

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
36 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00480103 on ClinicalTrials.gov